What is Lifecore Biomedical, Inc.'s market cap?

Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $162.4M and trades on NASDAQ.

What is Lifecore Biomedical, Inc.'s revenue and profitability?

Lifecore Biomedical, Inc. generated $125.9M in trailing twelve-month revenue with a net loss of $40.9M, representing a net margin of -30.0%. Gross margin stands at 31.3%, with free cash flow of -$9.2M. These figures are based on the Q2 2026 filing.

Who are Lifecore Biomedical, Inc.'s competitors?

Lifecore Biomedical, Inc.'s key competitors include Thermo Fisher Scientific, Baxter International, ADMA Biologics, Inc., and others. These companies compete in similar markets and product categories.

Who does Lifecore Biomedical, Inc. partner with?

Lifecore Biomedical, Inc.'s notable partners include BMO Harris Bank N.A., 22NW, LP.

Where is Lifecore Biomedical, Inc. headquartered?

Lifecore Biomedical, Inc. is headquartered in United States of America and employs approximately 459 people. It has been publicly traded since 1996.

Lifecore Biomedical, Inc.

LFCR

Market cap

$162.42M-38.3%

Revenue$125.9M-3.8%

Net income-$40.9M-680%

Free cash flow-$9.2M+67.2%

EPS (diluted)-$1.17-4,000%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q3 2027 report

May 6, 2026

Revenue$23.2MMiss by $2.8M EPS-$0.43Miss by $0.14

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$33.1M

EPS estimate-$0.22

Financials

Q4 2026

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation & ratios

Valuation

See full

Market cap$162.42M-38.3%

Enterprise value$298.55M+8.9%

P/S1.3×—

Returns & leverage

See full

Current ratio3.8×+0.9×

Segments

By product

See full

CDMO$15.8M-32.9%

HA manufacturing$7.4M-42.6%

By segment

See full

Reportable Segment$23.2M—

Competitors

By market cap

Thermo Fisher Scientific$211.18B+17.0%

Medpace Holdings, Inc.$16.8B+33.5%

Baxter International$11.6B-22.8%

ADMA Biologics$1.9B-55.4%

DiaMedica Therapeutics$362.9M+39.6%

Lifecore Biomedical, Inc.$162.4M-41.0%

ABVC BioPharma, Inc.$29.9M-41.5%

HCW Biologics$4.0M-63.1%

By revenue growth

Medpace Holdings, Inc.+24.7%

ADMA Biologics+11.0%

Thermo Fisher Scientific+5.6%

Baxter International+5.1%

Lifecore Biomedical, Inc.-3.8%

By net margin

ADMA Biologics32.43%-12.6pp

Medpace Holdings, Inc.17.67%-1.1pp

Thermo Fisher Scientific15.19%0.0pp

Baxter International-9.7%-4.5pp

Lifecore Biomedical, Inc.-30.04%-37.9pp

Profile

Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development and aseptic filling of complex, highly viscous sterile injectable pharmaceuticals and medical devices. The company is a leading manufacturer of non-animal-sourced hyaluronic acid (HA) and provides end-to-end services from analytical development to commercial-scale manufacturing. Their value proposition centers on proprietary fermentation processes and specialized capabilities in handling difficult-to-fill formulations for global biopharmaceutical partners.

Competitive position

A leading U.S. manufacturer of non-animal-sourced HA with specialized expertise in high-viscosity aseptic filling that serves as a high-barrier-to-entry niche.

GeographiesUnited States, Europe, Japan, Brazil

Customer segmentsBiopharmaceutical Companies, Medical Device Companies, Research Institutions

Business modelB2B, Contract Manufacturing (CDMO), Proprietary Manufacturing Process

SuppliersRaw material suppliers for fermentation, Specialized laboratory equipment providers, Aseptic filling machinery manufacturers

CustomersBiopharmaceutical marketing and distribution firms, Orthopedic clinics, Ophthalmic surgeons, Wound care providers

CountryUnited States of America

Listed1996

Employees459.0

CEOPaul Josephs

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Websitelifecore.com

FilingsSEC EDGAR

Ask your AI about Lifecore Biomedical, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s market cap?: Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $162.4M and trades on NASDAQ.
What is Lifecore Biomedical, Inc.'s revenue and profitability?: Lifecore Biomedical, Inc. generated $125.9M in trailing twelve-month revenue with a net loss of $40.9M, representing a net margin of -30.0%. Gross margin stands at 31.3%, with free cash flow of -$9.2M. These figures are based on the Q2 2026 filing.
Who are Lifecore Biomedical, Inc.'s competitors?: Lifecore Biomedical, Inc.'s key competitors include Thermo Fisher Scientific, Baxter International, ADMA Biologics, Inc., and others. These companies compete in similar markets and product categories.
Who does Lifecore Biomedical, Inc. partner with?: Lifecore Biomedical, Inc.'s notable partners include BMO Harris Bank N.A., 22NW, LP.
Where is Lifecore Biomedical, Inc. headquartered?: Lifecore Biomedical, Inc. is headquartered in United States of America and employs approximately 459 people. It has been publicly traded since 1996.